#abortion-pill

#abortion-pill

The Supreme Court will hear a case against the abortion pill mifepristone, which could have implications for access to the pill in the country.

A scientific paper raising concerns about the safety of mifepristone has been retracted by its publisher, citing a lack of scientific rigor and conflicts of interest. [ more ]

The Biden administration is opposing a lower court's decision to curtail the use of the abortion pill mifepristone, stating it would have disruptive consequences for women and the FDA.

The case represents a challenge to the FDA's power to regulate drugs and comes after the Supreme Court's decision to end federal abortion protections and overturn Roe v. Wade. [ more ]

The Supreme Court will hear a case about the abortion pill, mifepristone, with a ruling expected in June 2024.

The case challenges the FDA's approval of mifepristone and its prescribing regulations via telemedicine and beyond 7 weeks of pregnancy. [ more ]

The Supreme Court will decide on the availability of a commonly used abortion pill, which could limit access to medication used in over half of all pregnancy terminations in the US.

The case raises questions about the regulatory authority of the FDA and the role of the Supreme Court in ruling on abortion access even after its conservative majority declared it would leave the issue to the states. [ more ]